Please login to the form below

Rob Pilbrow joins OPEN Health as Global Managing Director, Medical Writing

OPEN Health Group have appointed Rob Pilbrow into the newly formed role of Global Managing Director, Medical Writing.

To strengthen our scientific communications expertise, OPEN Health Group have appointed Rob Pilbrow into the newly formed role of Global Managing Director, Medical Writing.

Rob will work across all three OPEN Health practices, supporting teams in the UK and US.

Rob said: “I’m delighted to be joining such a well-respected company at this exciting time in its journey, following the rebranding and consolidation of practices at the end of 2018. My role will focus on supporting the growth of OPEN Health’s medical writing and scientific services, to meet current and future business needs.”

Rob joins from the medical communications agency, Porterhouse Medical Group, where he served as Group Director, Scientific Services. He spent nearly 15 years at the Group, growing, developing and leading its medical writing function. In addition to his extensive medical communications experience, Rob brings a broad industry perspective across medical affairs, health economics and scientific publications. During his career, he has been awarded for efforts to support flexible working, receiving a Women in Business Role Model award in 2016, and last year, he was recognised as a Healthcare Communications Leader Finalist in the 2018 Communiqué Awards.

Commenting on Rob’s appointment, Michael J. McLaughlin, MD, Co-founder and Chief Scientific Officer of Peloton Advantage, an OPEN Health company, said: “Rob is a valuable addition to our dynamic team. His expertise is well suited to address our goal of providing the highest level of writing quality across the healthcare communications disciplines of our business units.”

Rob Barker, Chief Executive Officer of OPEN Health Medical Communications, added: “We are delighted that Rob has joined us to further strengthen our in-house medical writing function. The creation of this role demonstrates our commitment to medical and scientific excellence across the Group, and to adding industry-leading talent to our rapidly growing teams.”

12th August 2019

Share

Tags

Company Details

OPEN Health

+44 1628 481112

Contact Website

Address:
The Weighbridge
Brewery Courtyard
High Street
Marlow
Buckinghamshire
SL7 2FF
United Kingdom

Latest content on this profile

OPEN Health reflections on the World Orphan Drug Congress in Barcelona
Having just returned from a very busy but hugely enjoyable few days at congress, I wanted to share our views on the event and key themes that our healthcare communications practices took away from the discussions and presentations.
OPEN Health
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the care pathway for a patient, there appear to be inconsistencies within the same pharmaceutical organisations as to how patient journey mapping is defined.
OPEN Health
ESMO 2019 – the best bits!

OPEN Health
OPEN Health – committed to patient outcomes in rare oncology
We asked our Director of Rare Disease, Gavin Jones, and our Director of Oncology, Sean McGrath some key questions on rare oncology – watch the interview to find out more!
OPEN Health
ASCO 2019 – the highlights
Over 40,000 oncology professionals from around the world attended this year’s American Society of Clinical Oncology (ASCO) annual meeting. Sean McGrath, Director of Oncology at OPEN Health, recently attended and gives us an insight into the new data breakthroughs, highlights of this world-renowned congress. See the best bits here.
OPEN Health
OPEN Health announces the integration of Pharmerit International into the group
OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies.
OPEN Health